BioMedGPS announces expanded coverage of SmartTRAK Business Intelligence in the realm of Robotic and Computer Assisted Surgery with the launch of the US Computer Assisted Surgery (CAS) – Ortho module, debuting on Monday, November 5th.

The module provides real time, up-to-date market data, including 5-year market and procedural projections, quarterly revenue tracking, competitive overviews, clinical and regulatory activities and much more.

The new module covers:

• Robotics
• Navigation and surgical planning systems
• Augmented reality technologies 
• Artificial intelligence

The SmartTRAK Robotic and Computer Assisted Surgery module will be managed by Elise Wolf, Senior Analyst, a biomedical engineer that worked at a startup out of Carnegie Mellon University on robotic technologies early in her career.

Please join Elise Wolf for an introductory webinar on SmartTRAK’s newest product:

• Computer Assisted Surgery - Ortho – Tues, Nov. 13 - Register at www.smarttrak.com/cas-ortho
  

SmartTRAK is excited to be attending CNS 2018 - Congress of Neurological Surgeons - October 6-10 at George R. Brown Convention Center in Houston, TX.

SmartTRAK will be represented by Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies.

At CNS 2107, Anne did an interview with Dr. Ashwini Sharan, President of the Congress of Neurological Surgeons, on The Future of Robotic Spine Surgery, discussing current trends in robotic spine surgery, factors affecting growth in this market and future directions for this technology. To download a transcript of this fascinating interview, please click the button below.

 

Announcing the launch of the SmartTRAK Computer Assisted Surgery - Spine with a focus on surgical robotics. 

SmartTRAK’s Computer Assisted Surgery - Spine covers:

• Robotics
• Navigation and surgical planning systems
• Augmented reality technologies
• Artificial intelligence

The module provides real time, up-to-date market data, including 5-year market and procedural projections, quarterly revenue tracking, competitive overviews, clinical and regulatory activities and much more.

Foreign currency exchange rates boosted reported WW market growth, while the US market failed to rebound as expected

In Q218, positive foreign currency exchange rates boosted reported growth again in the WW Total Joints Market, while the US market grew sequentially but with a less-than-expected rebound following challenges in Q118...

Among the many topics covered in detail in the Q218 Total Joints Market Recap are:

Stability in the US and in International Growth

While the Spine market remains sluggish in the US, international sales are picking up the slack. The Q2 WW Spine Hardware market improved nearly 2% during the quarter despite...

Among the many topics covered in the Q218 Spine Market Recap are:

Computer Assisted Surgery - Spine is the latest module added to SmartTRAK Business Intelligence and Will Be Launched at the North American Spine Surgery (NASS) Meeting

BioMedGPS announces expanded coverage of SmartTRAK Business Intelligence in the realm of Robotic and Computer Assisted Surgery with the launch of its first module, US Computer Assisted Surgery (CAS) – Spine at the upcoming NASS conference later this month. A second SmartTRAK module, US Computer Assisted Surgery (CAS) – Ortho, will be introduced in November.

Extremities market experiences slight gains due to expanded product portfolios 

The US Extremities Market experienced a slight gain in Q218 according to SmartTRAK Financial Dashboard, slightly lower than the rate anticipated in the US Extremities Market Overview. We anticipate the Extremities segment rebounding to achieve...

Among the many topics covered in the Q218 Extremities Market Recap are:

• Competition in Shoulders Heating Up
• Expanded Portfolios and Awareness Driving Continued Ankle Growth
• Extremities Fixation: Company Focus and New Product Intros Incite Growth
• Regulatory Highlights

US market experiences slight softening as the top four trauma players all post sequential declines in Q218

The WW Trauma Market was up in Q218 – the third consecutive quarter of growth in the +4% range. Internationally, positive sales growth in Europe offset a sequential slowdown in Rest of World (ROW). In Europe, revenues were steady, while ROW sales dipped sequentially as the top players reported softer growth due to tough comps as a result of 2017 tender orders...

Among the many topics covered Q218 Trauma Market Recap are:

Volume Up, Pricing Down, Overall Market Lower

Now that Q218 results are in, the US Joint Fluid market continued to experience downward pressure posting negative growth of -6.5% for the quarter and -4.0% YTD, according to SmartTRAK Financial Dashboard results ...

Cerapedics’ CEO Glen Kashuba and President and COO Jeff Marx, Ph.D. discuss the future of the bone graft substitutes and the uniqueness of i‑FACTOR Peptide Enhanced Bone Graft, a small peptide technology in an interview with Kim French, Sr. Analyst, SmartTRAK Orthbio.

A transcript of SmartTRAK's interview with Glen Kashuba and Jeff Marx is below, or click on the following video to listen to the interview.